-
-
-
-
-
-
-
Heat Biologics (HTBX) Unveils Enhanced Allogeneic Cell Manufacturing Process
-
-
-
-
-
-
-
Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIMĀ®, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human Services
-
-
-
-
-
-
-
Pre-Open Movers 11/21: (ABIL) (FL) (TNDM) Higher; (HTBX) (CAL) (DE) Lower (more...)
-
-
-
-
-
-
-
Heat Biologics (HTBX) Prices $18 Million Public Offering
-
-
-
-
-
-
-
Heat Biologics (HTBX) Announces Proposed Common Share Offering
-
-
-
-
-
-
-
Pre-Open Movers 03/23: (HTGM) (SSH) (PVH) (FEYE) Higher; (HTBX) (RARE) (BLCM) Lower (more...)
-
-
-
-
-
-
-
Heat Biologics Announces Agreement to Acquire Pelican Therapeutics
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

